Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-14

Trupanion, Inc. (TRUP) Stock Forecast Oct. 14, 2026

Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D ▼ Bearish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Bottom 35% of 4004 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $1.17B small-cap · #10 of 10 peers
Summary

Trupanion, Inc. (TRUP) stock forecast summary

Our AI ranks Trupanion, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Trupanion, Inc. is a small-cap company with a market capitalization of $1.17B. It ranks number 10 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its Current Ratio of 1.77x is the highest of the 10 peers that report one.

A per-ticker accuracy statistic for TRUP is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, TRUP included.

Follow TRUP free
Price

TRUP price chart and AI forecast

TRUP
Cross-section · 2026-10-14

How TRUP ranks among 4004 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Trupanion, Inc. (TRUP) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.

Valuation & Market

MetricTRUPIndustry medianRank
Market Cap $1.17B $22.48B 10/10
P/B Ratio 2.85x 2.74x 5/10
EPS $0.39 – –
Book Value/Share $9.34 – –
Revenue/Share $34.66 – –
FCF/Share $1.87 – –

Profitability & Margins

MetricTRUPIndustry medianRank
ROE 5.7% 8.6% 6/8
ROA 2.5% 3.2% 5/8
ROIC 4.6% 6.9% 7/10
Gross Margin 16.5% 54.6% 5/6
Operating Margin 1.6% 1.7% 6/10
Net Margin 1.5% 1.9% 5/8
EBT Margin 1.7% 1.4% 5/10
Tax Rate 11.5% – –

Financial Health

MetricTRUPIndustry medianRank
Current Ratio 1.77x 1.51x 1/10
D/E Ratio 1.27x 2.38x 9/10
Financial Leverage 2.27x 3.42x 9/10
Interest Coverage 3.5x 7.5x 8/9
Working Capital $314M $580M 7/10

Cash Flow

MetricTRUPIndustry medianRank
Operating Cash Flow $94M $3.13B 9/10
Free Cash Flow $82M $1.27B 8/9
Capital Spending -$12M -$94M 2/9
OCF Growth YoY 34.4% 34.4% 5/9
FCF Growth YoY 34.0% 25.9% 4/8
FCF/Sales 5.4% 3.9% 2/9
CapEx/Sales 0.8% 0.4% 1/9

Operational Efficiency

MetricTRUPIndustry medianRank
Asset Turnover 1.63x 2.12x 7/10
Fixed Assets Turnover 15.0x 72.4x 10/10
Payables Period 3 days – –

Income Statement

MetricTRUPIndustry medianRank
Total Revenue $1.52B $90.86B 10/10
Operating Income $24M $416M 8/10
Net Income $23M $840M 6/8
SG&A Expense $241M $13.59B 8/8
Cost of Goods Sold $1.27B $30.37B 6/6

Dividend & Shareholder Information

MetricTRUPIndustry medianRank
Shares Outstanding 44M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$719M77.3% of assets
Cash & Short-term Investments$149M16.0% of assets
Total Liabilities$521M56.0% of assets
Short-term Debt$394M42.3% of assets
Quarterly Financial Reports

TRUP quarterly financials and insider trading

Industry Peers · Hospital & Medical Service Plans

Trupanion, Inc. (TRUP) industry peers

Companies classified under the same SEC industry code as Trupanion, Inc. (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
TRUP Trupanion, Inc. ▼ $1.17B – 2.9x
UNH Unitedhealth Group Inc ▲ $339.08B 24.0x 3.4x
ELV Elevance Health, Inc. ▲ $92.23B 18.6x 2.1x
CI Cigna Group ▲ $74.66B 11.6x 1.8x
HUM Humana Inc ▲ $50.47B 39.8x 2.4x
CNC Centene Corp ▲ $34.02B – 1.5x
MOH Molina Healthcare, Inc. ▲ $10.94B – 2.6x
OSCR Oscar Health, Inc. ▲ $10.43B 18.9x 5.1x
CLOV Clover Health Investments, Corp. /De ▲ $2.55B – 6.8x
ALHC Alignment Healthcare, Inc. ▲ $1.72B – 6.5x

Where TRUP sits on the market map

Finance · Hospital & Medical Service Plans
Explore the map →
News

Trupanion, Inc. (TRUP) stock news

Loading...

FAQ

Trupanion, Inc. (TRUP) stock forecast FAQ

What is the Trupanion, Inc. (TRUP) stock forecast?

Our AI ranks Trupanion, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Trupanion, Inc. stock predictions?

A per-ticker accuracy statistic for TRUP is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Trupanion, Inc. forecasts updated?

Trupanion, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Which companies are Trupanion, Inc.'s industry peers?

10 issuers in our coverage, TRUP included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.